Company Profile - Personalis Inc

Introduction

Personalis Inc (Personalis) provides genomic sequencing and analytics solutions for developing vaccines to treat cancers. The company develops end-to-end solutions for immuno-oncology through its Immunoid NeXT Platform. It also helps in identifying therapies and clinical trials to treat cancer patients using NeXT Dx Test, a genomic testing solution. Personalis also offers next-generation sequencing (NGS) assays for the generation and interpretation of molecular data. The company uses accuracy and content-enhanced technology for developing its products. It partners with biopharmaceutical companies for developing cancer therapies and also for personalized medicines. The company is a spin-off from Stanford University. It has an operational presence in the US and the UK. Personalis is headquartered in Menlo Park, California, the US